The aim of this new statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …

Background and Purpose—This guideline provides an overview of the evidence on various
established and potential stroke risk factors and provides recommendations for the reduction …

This scientific statement is intended for use by physicians and allied health personnel caring
for patients with transient ischemic attacks. Formal evidence review included a structured …

Apolipoprotein E, type ϵ4 allele (APOE ϵ4), is associated with late-onset familial
Alzheimer's disease (AD). There is high avidity and specific binding of amyloid β-peptide …

Purpose—Our goal is to provide an overview of the current evidence about components of
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …

An open angiography‐based, dose rate escalation study on the effect of intravenous
infusion of recombinant tissue plasminogen activator (rt‐PA) on cerebral arterial …

Context Clinicians and trialists have difficulty with identifying which patients are highest risk
for cardiovascular events. Prior ischemic events, polyvascular disease, and diabetes …

A genetic component in the etiology of Alzheimer disease (AD) has been supported by
indirect evidence for several years, with autosomal dominant inheritance with age …

Patient delay in seeking treatment for acute coronary syndrome and stroke symptoms is the
major factor limiting delivery of definitive treatment in these conditions. Despite decades of …

ObjectiveTo develop recommendations for the establishment and operation of primary
stroke centers as an approach to improve the medical care of patients with stroke …